Procedures designed to prevent microbiological contamination of diug products pmpo1ting to be sterile are not established and followed.
Inspection Record
Fresenius Kabi Oncology Limited — FDA 483 Findings
Inspectors Justin A Boyd · Anastasia M ShieldsThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic process.
Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.
Written procedures are not established for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.
Established test procedures are not documented at the time ofperformance.
Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the equipment to produce aseptic conditions.
Batch production and control records do not include complete information relating to the production and control of each batch.
Laboratory records do not include complete data derived from all tests, examinations and assay necessary to assure compliance with established specifications and standards.
The responsibilities and procedures applicable to the quality control unit are not fully followed.
There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed.
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Suzhou Suncadia Biopharmaceutical CO., Ltd.2023-12-14 · US FDASimilar to finding 1 Procedures designed to preyent microbiological contamination of drug products purporting to be sterile are not established and fo1lowed.
- Sterigenics US , LLC2022-08-23 · US FDASimilar to finding 9 The responsibilities and procedures applicable to the quality control unit are not fully followed.
- RayzeBio, Inc2026-02-24 · US FDASimilar to finding 11 Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
- Maiva Pharma Private Limited2026-02-20 · US FDASimilar to finding 7 Production records do not contain complete information relating to the production and control of each batch.
- Mixlab WI LLC2025-07-24 · US FDASimilar to finding 7 Batch production and control records do not include complete information relating to the production and control of each batch.
A record as of the US FDA document published on 2024-12-05. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.